These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29535594)

  • 1. Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.
    Dabrowska M; Juzwa W; Krzyzosiak WJ; Olejniczak M
    Front Neurosci; 2018; 12():75. PubMed ID: 29535594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for Huntington's Disease Using Targeted Endonucleases.
    Dabrowska M; Olejniczak M
    Methods Mol Biol; 2020; 2056():269-284. PubMed ID: 31586354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model.
    Ekman FK; Ojala DS; Adil MM; Lopez PA; Schaffer DV; Gaj T
    Mol Ther Nucleic Acids; 2019 Sep; 17():829-839. PubMed ID: 31465962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting N-Terminal Huntingtin with a Dual-sgRNA Strategy by CRISPR/Cas9.
    Wu J; Tang Y; Zhang CL
    Biomed Res Int; 2019; 2019():1039623. PubMed ID: 31828084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.
    Alkanli SS; Alkanli N; Ay A; Albeniz I
    Mol Neurobiol; 2023 Mar; 60(3):1486-1498. PubMed ID: 36482283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat.
    McLean ZL; Gao D; Correia K; Roy JCL; Shibata S; Farnum IN; Valdepenas-Mellor Z; Kovalenko M; Rapuru M; Morini E; Ruliera J; Gillis T; Lucente D; Kleinstiver BP; Lee JM; MacDonald ME; Wheeler VC; Mouro Pinto R; Gusella JF
    Nat Commun; 2024 Apr; 15(1):3182. PubMed ID: 38609352
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    McLean ZL; Gao D; Correia K; Roy JCL; Shibata S; Farnum IN; Valdepenas-Mellor Z; Rapuru M; Morini E; Ruliera J; Gillis T; Lucente D; Kleinstiver BP; Lee JM; MacDonald ME; Wheeler VC; Pinto RM; Gusella JF
    bioRxiv; 2023 Jul; ():. PubMed ID: 37547003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts.
    Ciesiolka A; Stroynowska-Czerwinska A; Joachimiak P; Ciolak A; Kozlowska E; Michalak M; Dabrowska M; Olejniczak M; Raczynska KD; Zielinska D; Wozna-Wysocka M; Krzyzosiak WJ; Fiszer A
    Cell Mol Life Sci; 2021 Feb; 78(4):1577-1596. PubMed ID: 32696070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.
    Imbert M; Blandel F; Leumann C; Garcia L; Goyenvalle A
    Nucleic Acid Ther; 2019 Oct; 29(5):256-265. PubMed ID: 31184975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
    Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
    Shin JW; Kim KH; Chao MJ; Atwal RS; Gillis T; MacDonald ME; Gusella JF; Lee JM
    Hum Mol Genet; 2016 Oct; 25(20):4566-4576. PubMed ID: 28172889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models.
    Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A
    BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 mediated genome editing of Huntington's disease neurospheres.
    Han JY; Seo J; Choi Y; Im W; Ban JJ; Sung JJ
    Mol Biol Rep; 2023 Mar; 50(3):2127-2136. PubMed ID: 36550260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
    J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MID1 Protein: A Promising Therapeutic Target in Huntington's Disease.
    Heinz A; Schilling J; van Roon-Mom W; Krauß S
    Front Genet; 2021; 12():761714. PubMed ID: 34659371
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.